By Dan Primack
November 8, 2012

The Carlyle Group has abandoned its efforts to acquire British military ammunitions and defense company Chemring Group PLC (LSE: CHG), which currently is valued at just under £500 million. Since Carlyle originally expressed interest in Chemring two months ago, the company has repeatedly cut its earnings forecasts, ousted its CEO and seen UK regulators cast a skeptical eye on the sale. Shortly after Carlyle’s original expression of interest, Chemring’s market cap climbed to more than £800 million.

Bausch + Lomb, a Rochester, N.Y.-based eye care company, has exercised its option to buy the remaining shares of Technolas Perfect Vision, a German ophthalmology laser company. No financial terms were disclosed. Bausch + Lomb shareholders include Warburg Pincus, Thomas McNerney & Partners and Welsh Carson Anderson & Stowe.

Cortec Group has acquired a majority stake in BarcodesInc from Thompson Street Capital Partners. No financial terms were disclosed. BarcodesInc is a Chicago-based provider of barcode, mobile computing, point of sale and RFID solutions.

Endeavor Capital has agreed to acquire Access Scientific Inc., a San Diego-based provider of over-wire vascular access technology. No financial terms were disclosed.

LLM Capital Partners and Hickory Ridge Capital have acquired Best Practice Disease Management Inc., a provider of in-home health risk assessments for Medicare Advantage Plans. No financial terms were disclosed.

Kohlberg Kravis Roberts & Co. and Allegro Funds (Australia) have agreed to acquire a portfolio of distressed commercial loans from BOS International, a subsidiary of Lloyds International Pty Ltd. The loans have a A$350 million face value, but no terms of the transaction were disclosed.

Sign up for Dan’s daily email newsletter on deals and deal-makers:

You May Like